Evidence map›Paper›PMID 26649300›Full record

ReviewBioMed research international2015

Ordinary and Activated Bone Grafts: Applied Classification and the Main Features.

R V Deev, A Y Drobyshev, I Y Bozo, A A Isaev

Registry-linked trialAbstract readReview
In one paragraph

Review in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03076138 (The Clinical Trial of the Safety and Efficacy of the Medical Device "Bone Substitute Based on Octacalcium Phosphate and Biologically Active Nucleic Acids for Bone Tissue Regeneration"), which is not on this map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03076138 nacompletednot on this mapstarted 2017, after this paper: background citation

The Clinical Trial of the Safety and Efficacy of the Medical Device "Bone Substitute Based on Octacalcium Phosphate and Biologically Active Nucleic Acids for Bone Tissue Regeneration" (Nucleostim-VEGF)

TypeinterventionalSponsorHistograft Co., Ltd.Ran2017 to 2018Enrolled20ConditionsBone Cysts, Bone Atrophy, Bone Deformity, Bone FractureArmsGene-activated matrix (OCP + plasmid DNA with VEGF gene)
3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Research Progress of Bone Grafting: A Comprehensive Review.International journal of nanomedicine · 2025
    Review
  2. Endogenous Regeneration of Alveolar Bone by Decellularized Tooth Matrix.Bulletin of experimental biology and medicine · 2023
    Article
  3. Article
  4. Bone Augmentation for Implant Placement: Recent Advances.International journal of dentistry · 2022
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

R V DeevHuman Stem Cells Institute, Moscow 199333, Russia ; Department of Morphology and General Pathology, Kazan (Volga Region) Federal University, Kazan 420008, Russia.
A Y DrobyshevDepartment of Maxillofacial and Plastic Surgery, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow 127473, Russia.
I Y BozoHuman Stem Cells Institute, Moscow 199333, Russia ; Department of Maxillofacial and Plastic Surgery, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Moscow 127473, Russia ; Department of Maxillofacial Surgery, A.I. Burnasyan Federal Medical Biophysical Center, Moscow 123098, Russia.
A A IsaevHuman Stem Cells Institute, Moscow 199333, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone grafts are medical devices that are in high demand in clinical practice for substitution of bone defects and recovery of atrophic bone regions. Based on the analysis of the modern groups of bone grafts, the particularities of their composition, the mechanisms of their biological effects, and their therapeutic indications, applicable classification was proposed that separates the bone substitutes into "ordinary" and "activated." The main differential criterion is the presence of biologically active components in the material that are standardized by qualitative and quantitative parameters: growth factors, cells, or gene constructions encoding growth factors. The pronounced osteoinductive and (or) osteogenic properties of activated osteoplastic materials allow drawing upon their efficacy in the substitution of large bone defects.

Indexed as

Bone RegenerationBone SubstitutesBone TransplantationHumansBone Substitutes

Identifiers

PMID26649300
PMCPMC4662978

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.